This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
ORAI1 · Western blot design guide
ORAI1 Western Blot Planning Guide
Plan an ORAI1 Western blot around the catalog-observed 32.7 kDa band, image-backed A00909 evidence, HPA controls, and verified protocol records.
Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
ORAI1 Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | 32.7 kDa | |
| Observed band | Not reported — verify product WB image | |
| Gel | 12-15% | |
| Positive control | Skin | |
| Negative control | Bone marrow |
Important caveats
Reasons your observed band may differ from the expected size.
| ⓘ | Calculated mass | 32.7 kDa |
| ⓘ | Localization | Cell membrane / Basolateral cell membrane |
| ⓘ | Processing / PTM | Record-dependent |
| ⓘ | Reactivity | Human / Mouse / Rat |
Section 1
Real Curated ORAI1 Western Blot Protocols
Start with the molecular-weight rule, then compare verified publication-derived conditions.
| Sample / lysate | Skin |
| Gel % | 12-15% |
| Load | 20-30 µg total protein per lane |
| Transfer | Semi-dry, standard transfer |
| Membrane | 0.45 µm PVDF |
| Blocking | 5% non-fat milk or 5% BSA in TBST |
| Primary | A00909 at datasheet starting dilution |
| Primary incubation | Overnight at 4 °C with gentle agitation |
| Secondary | Species-matched HRP conjugate at validated dilution |
| Wash | 3 × 5 min in TBST |
| Detection | Chemiluminescent substrate |
| Exposure | Bracket exposures to avoid saturation |
Section 2
What Is the Expected ORAI1 Western Blot Band Size?
Use the product-observed 32.7 kDa band as the primary planning value and retain the UniProt calculated mass as context.
| 32.7 kDa | Matches the authoritative product WB observation. |
| 32.7 kDa calculated | Use as UniProt context, not as a replacement observed band. |
| Unexpected additional signal | Do not assign identity without orthogonal positive/negative controls. |
💡Expected ORAI1 appearancePlan around 32.7 kDa and keep the calculated mass as supporting context.
| Catalog-observed band | 32.7 kDa; use this as the primary experimental expectation. |
| Calculated mass | 32.7 kDa from UniProt Q96D31; retain as context. |
| Gel selection | 12-15%; shared with the recommended protocol and poster. |
| Specificity check | Compare the lead HPA positive and negative controls with A00909. |
| Situation | Likely cause | Next action |
|---|---|---|
| 32.7 kDa | Matches the authoritative product WB observation. | Confirm with orthogonal controls and the linked product record. |
| Additional band | May reflect processing, modification, or non-specific signal. | Run a dilution series and compare positive/negative controls. |
| Weak signal | Target abundance or transfer may be limiting. | Verify transfer, increase positive-control abundance, and bracket exposure. |
Experiment evidence
Western blot images showing ORAI1 band
A00909 · ORAI1
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for ORAI1 Western blot
🧪Use Skin as the first positive-control candidate and Bone marrow as the HPA Not detected negative candidate.
Positive control: Skin (High)
Negative control: Bone marrow (Not detected)
HPA protein score determines control status; other expression data is supporting context only.
HPA tissue expression evidence for ORAI1
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Skin | Reported tissue cells | High | Protein (HPA) | HPA → |
| Testis | Reported tissue cells | High | Protein (HPA) | HPA → |
| Cervix | Reported tissue cells | Medium | Protein (HPA) | HPA → |
| Esophagus | Reported tissue cells | Medium | Protein (HPA) | HPA → |
Section 3
Advanced ORAI1 Western Blot Tips
Deeper troubleshooting and optimisation questions for ORAI1, answered from its protein features.
Which band should guide the blot?
Use 32.7 kDa, the observation attached to the authoritative A00909 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 32.7 kDa expectation.
Which positive control should I start with?
Start with Skin, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Bone marrow as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for ORAI1 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A00909 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC9114653, PMC9597359, PMC9180186.
Boster reagents
ORAI1 Western Blot Reagents
Human/Mouse/Rat-reactive ORAI1 Western blot reagents with authoritative product imagery.
Real WB data
Anti-Orai1 Antibody Picoband®
Cat # A00909
Real WB data
Anti-Orai1 Antibody Picoband®
Cat # PA1857
Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.
Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.
References
- UniProt Q96D31
- Human Protein Atlas — ORAI1
- A00909 product record
- PMC9114653 — SPLUNC1 is a negative regulator of the Orai1 Ca(2+) channel.
- PMC9597359 — Orai1-mediated store-operated Ca(2+) entry promotes cervical cancer progression through IL-6 signaling.
- PMC9180186 — ORAI1-Regulated Gene Expression in Breast Cancer Cells: Roles for STIM1 Binding, Calcium Influx and Transcription Factor Translocation.